نتایج جستجو برای: cyp2c19 enzyme

تعداد نتایج: 242459  

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2011
Kaisa A Salminen Jukka Leppänen Jarkko I Venäläinen Markku Pasanen Seppo Auriola Risto O Juvonen Hannu Raunio

Many clinically relevant drug interactions involving cytochrome P450 inhibition are mediated by mechanism-based inactivation (MBI). Time-dependent inhibition is one of the major features distinguishing between reversible inhibition and MBI. It thus provides a useful screening approach for early drug interaction risk assessment. Accordingly, we developed an easy and informative fluorometric meth...

Journal: :Egyptian Journal of Medical Human Genetics 2022

Abstract Background The prevalence and the role of CYP2C19 gene mutations concerning recurrent Cardiovascular Events (CVEs) among patients treated with clopidogrel is still controversial especially Arab people. Therefore, this review aimed to determine frequency polymorphic alleles population investigate efficacy as an antiplatelet drug those carrying different variants gene. Methodology Two au...

2017
S Ryu S Park JH Lee YR Kim HS Na HS Lim HY Choi IY Hwang JG Lee ZW Park WY Oh JM Kim SE Choi

We performed a double-blinded, genotype-based stratification study to explore the pharmacokinetics and pharmacodynamics of amitriptyline according to CYP2C19 and CYP2D6 genotype in Korean subjects. Twenty-four healthy adults were grouped by genotype of CYP2C19 and CYP2D6. After a single dose of 25 mg of amitriptyline, blood samples were collected and anticholinergic effects were measured. The e...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2017
Ming-Chih David Ho Nicholas Ring Kirsten Amaral Utkarsh Doshi Albert P Li

We report in this work successful isolation and cryopreservation of enterocytes from human small intestine. The enterocytes were isolated by enzyme digestion of the intestinal lumen, followed by partial purification via differential centrifugation. The enterocytes were cryopreserved directly after isolation without culturing to maximize retention of in vivo drug-metabolizing enzyme activities. ...

2008
Robin E. Pearce Wei Lu YongQiang Wang Jack P. Uetrecht Maria Almira Correia J. Steven Leeder

Conversion of the carbamazepine metabolite, 3-hydroxycarbamazepine (3-OHCBZ), to the catechol, 2,3dihydroxycarbamazepine (2,3-diOHCBZ), followed by subsequent oxidation to a reactive o-quinone species has been proposed as a possible bioactivation pathway in the pathogenesis of carbamazepineinduced hypersensitivity. Initial in vitro phenotyping studies implicated CYP3A4 as a primary catalyst of ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2009
Alaa-Eldin F Nassar Ivan King Brandy L Paris Lois Haupt Florence Ndikum-Moffor Rebecca Campbell Etsuko Usuki Jennifer Skibbe Dan Brobst Brian W Ogilvie Andrew Parkinson

Laromustine (VNP40101M, also known as Cloretazine) is a novel sulfonylhydrazine alkylating (anticancer) agent. Laromustine generates two types of reactive intermediates: 90CE and methylisocyanate. When incubated with rat, dog, monkey, and human liver microsomes, [(14)C]laromustine was converted to 90CE (C-8) and seven other radioactive components (C-1-C-7). There was little difference in the me...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2012
Verònica Ventura Josep Solà Concepción Peraire Françoise Brée Rosendo Obach

Irosustat is a first-generation, irreversible, steroid sulfatase inhibitor currently in development for hormone-dependent cancer therapy. To predict clinical drug-drug interactions between irosustat and possible concomitantly administered medications, the inhibition/induction potential of irosustat with the main drug-metabolizing enzymes was investigated in vitro. The interaction of aromatase i...

Journal: :European Heart Journal 2022

Abstract Background Patients carrying loss-of-function (LOF) variants of CYP2C19 or using the CYP2C19-inhibitors omeprazole esomeprazole cannot fully bioactivate clopidogrel, and thus are lacking optimal thrombosis prevention. However, clopidogrel is a relevant alternative to ticagrelor due its lower incidence hemorrhagic events cost. Purpose The purpose this study was investigate in real-life ...

Journal: :American journal of physiology. Heart and circulatory physiology 2016
Tomonori Akasaka Daisuke Sueta Yuichiro Arima Noriaki Tabata Seiji Takashio Yasuhiro Izumiya Eiichiro Yamamoto Megumi Yamamuro Kenichi Tsujita Sunao Kojima Koichi Kaikita Ayami Kajiwara Kazunori Morita Kentaro Oniki Junji Saruwatari Kazuko Nakagawa Yasuhiro Ogata Kunihiko Matsui Seiji Hokimoto

Categorization as a cytochrome P450 (CYP) 2C19 poor metabolizer (PM) is reported to be an independent risk factor for cardiovascular disease. Epoxyeicosatrienoic acids (EETs) are metabolites of arachidonic acid by CYP2C19 epoxygenases and anti-inflammatory properties, especially in microvascular tissues. We examined the association of CYP2C19 polymorphisms and EETs on microvascular angina (MVA)...

Journal: :Genetics and molecular research : GMR 2016
Y M Guo Z C Zhao L Zhang H Z Li Z Li H L Sun

The goal of this study was to explore the polymorphisms of CYP2C19 (CYP2C19*2, CYP2C19*3) in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) on clopidogrel therapy in Zhengzhou city for guidance on clinical medication and reduction in the incidence of thromboembolic events. Two hundred and thirty-four ACS patients undergoing PCI were included in t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید